Skip to content
TrustList
5AM Ventures logo
Venture capital firm

5AM Ventures

Life-science venture and public equity investor building biopharma, drug delivery and instrument companies

5AM Ventures cover

About 5AM Ventures

Two investment strategies

Life-science companies, from academic discoveries to later-stage biotech, are the focus of 5AM Ventures, a firm founded in 2002 that builds companies as well as funding them. Its areas are biopharmaceuticals, drug delivery and life-science instruments, and it describes its aim as building next-generation companies that can address important healthcare needs.

The venture strategy mainly invests in private therapeutic companies at an early stage, with an emphasis on Series A financings. The opportunities strategy invests in small and mid-cap public biotech companies and in later-stage private life-science companies. Together the two strategies give the firm exposure to companies at very different points in their development.

The 4:59 initiative

The 4:59 initiative is the firm's hands-on internal effort to discover, incubate and fund breakthrough science. Working with academics and entrepreneurs, 5AM often acts as an extension of their operating team, helping them establish proof-of-concept data that can support a Series A financing.

Track record and recent portfolio news

The firm says patients enrolled in trials run by its portfolio companies number more than ninety thousand, across more than 450 sites. Its recent news covers clinical results, financings and public offerings among portfolio companies. Examples include CAMP4, which is preparing a first-in-human trial for a rare disease linked to SYNGAP1 after receiving clearance in Australia, and Dianthus, IDEAYA, Vor Bio and Rezera, which the firm lists among companies it has supported.

TrustList summary

5AM Ventures is a life-science investment firm founded in 2002. It concentrates on biopharmaceuticals, drug delivery technologies and life-science instruments, and it also helps to create companies as well as fund them.

Services

  • Venture strategy: mainly early-stage investment in private therapeutic companies, with an emphasis on Series A.
  • Opportunities strategy: investment in small and mid-cap public biotech and later-stage private life-science companies.
  • 4:59 Initiative: an internal effort to discover, incubate and fund early science, building the data needed for a first funding round.

Who it serves

Academics and entrepreneurs with early scientific ideas, and biotech companies in clinical development.

Key facts

  • Founded: 2002
  • Focus: biopharmaceuticals, drug delivery and instruments
  • Track record: portfolio companies have enrolled over 90,000 patients across more than 450 clinical trial sites
  • Portfolio news: includes Dianthus, IDEAYA, Vor Bio and CAMP4

Summary written by TrustList from the business's own published information, Nov 2026.

Categories & features

5AM Ventures rankings

5AM Ventures is ranked on 3 TrustList rankings: #10 on 1, #11 on 1 and #18 on 1.

Every ranking orders its listings by their reviews, how complete the profile is and the Trust Score. 5AM Ventures has no reviews yet and 3 of the 10 profile details we look for. Where no listing on a page has been reviewed, the order follows the profiles alone.

Venture capital firm · 3 rankings

  • #10of 77
    Biotech investors

    It is one of 17 here listing science.

    Of the top 65 here, 22 also cover healthtech and 17 also cover science; 14 also work in Boston and 13 also work in San Francisco.

    Ahead of BVCF Management.

  • #11of 102
    Boston

    It is one of 11 here listing biotech.

    Of the top 69 here, 11 also cover biotech and 10 also cover seed stage; 21 also work in London and 18 also work in New York City.

    Behind Flagship Pioneering, ahead of Bain Capital Ventures.

  • #18of 172
    San francisco

    It is one of 4 here listing biotech and science.

    Of the top 53 here, 10 also cover partners and 9 also cover artificial intelligence; 16 also work in Silicon Valley and 5 also work in Hong Kong.

    Ahead of CFO Rick, Inc..

As of 2026-11-16. Organic ranks only; sponsored placements are never ranks. How TrustList ranks

What the business tells TrustList

Founded
2002 (24 years) evidence sent

Ask TrustList to introduce you to 5AM Ventures

TrustList reads every request before passing it on, and sends it only where the funder's stage and focus look like a fit. We do not charge for introductions, and we cannot promise a reply.

Protected by reCAPTCHA - Google Privacy Policy and Terms apply.

Reviews

Write the first review of 5AM Ventures

Used it? Your experience helps other buyers decide.

Write a review

Questions & answers

No questions yet. Be the first to ask about 5AM Ventures.

5AM Ventures alternatives

Similar listings buyers compare against this one.

Venture programme of Research Corporation Technologies investing in early-stage biomedical and life science companies

Boutique M&A advisory firm for sell-side and buy-side deals in business technology, finance and industrials

A life sciences venture fund investing in biotechnology and biopharma companies across multiple stages

UK build-to-rent housing developer and manager delivering new family rental homes

Growth fund backed by tech founders, investing in African technology companies as they scale

Estonian investment company backing fast-growing digital businesses in crypto, software and SaaS

A venture capital fund investing in early-stage artificial intelligence companies since 2017